Skip to main content
. Author manuscript; available in PMC: 2017 Apr 24.
Published in final edited form as: Endocr Pract. 2017 Jan 17;23(4):442–450. doi: 10.4158/EP161540.OR

TABLE 1.

Patient and Nodule Characteristics (n = 639)

Variable Number (%)
Age (years) 52.0 ± 14.7
Female gender 501 (78.5)
Radiation history 26 (4.1)
Family history of thyroid cancer 92 (14.4)
Median TSH (U/mL) 1.5 ± 3.6
Taking levothyroxine 90 (14.1)
Median nodule size (cm) 2.3 ± 1.5
  Cytology
Follicular neoplasm 288 (45.1)
Hurthle cell neoplasm 130 (20.3)
AUS/FLUS 121 (18.9)
Suspicious for PTC 100 (15.7)
  Extent of Surgery
Lobectomy 376 (58.8)
Total thyroidectomy 263 (41.2)
  Final Pathology
Total Cancers 228 (35.7)
Cancer ≥ 1 cm 158 (24.7)
Cancer < 1 cm 70 (10.9)

Data are represented as either the mean or median value ± the standard deviation for continuous variables or the number of patients with the corresponding percentage for categorical variables. U = units, mL = millimeters, cm = centimeters, AUS = atypia of undetermined significance, FLUS = follicular lesion of undetermined significance, PTC = papillary thyroid cancer